Speakers: Genevieve Boland, Associate Professor of Surgery at Harvard Medical School & Arnav Mehta, Postdoctoral researcher in Immunology at the Broad Institute of MIT and Harvard
Aug 12, 2021 10:30:47 AM / by Olink posted in Immunotherapy, Oncology, Multiomics, Clinical research
Speakers: Genevieve Boland, Associate Professor of Surgery at Harvard Medical School & Arnav Mehta, Postdoctoral researcher in Immunology at the Broad Institute of MIT and Harvard
Olink offers an unmatched high-multiplex technique to identify actionable biomarkers, with a strong focus on the human plasma proteome. Using minimal sample volume we provide quantifiable results with high-throughput, exceptional sensitivity and specificity, with coverage across a broad dynamic range. Our mission is to accelerate proteomics together with the scientific community across multiple disease areas to enable new discoveries and better understand complex real-time human biology. We are committed to develop our offering and are continuously expanding our protein coverage for a growing number of biological processes and pathways.
Olink is well-established in Europe (HQ Uppsala, Sweden) and the USA (HQ Boston, MA), with a rapidly developing presence across Asia. We also work with a growing number of core labs around the world offering analysis and support to an expanding global customer base.